SCHEMBL541372

SCHEMBL541372

C=C(C)C(=O)OCCCCC(C[N+](C)(C)C)OP(=O)(O)O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
POLB P06746 1/20 0.36
APEX1 P27695 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
THRB P10828 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
SMPD1 P17405 3/20 0.32
ALDH1A1 P00352 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
HRH1 P35367 1/20 0.31
KMT2A Q03164 1/20 0.31
RAD52 P43351 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GALR3 O60755 1/20 0.30
MAPT P10636 1/20 0.30
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28062034 0.99 TSHR (0.47) TSHRPOLBAPEX1HTTTDP1
SCHEMBL541808 0.99 TSHR (0.47) TSHRPOLBAPEX1HTTTDP1
SCHEMBL541106 0.99 TSHR (0.47) TSHRPOLBAPEX1HTTTDP1
SCHEMBL541861 0.96 TSHR (0.42) TSHRPOLBAPEX1HTTTDP1
SCHEMBL6852709 0.93 TSHR (0.42) TSHRPOLBAPEX1HTTTDP1
SCHEMBL176508 0.91 THRB (0.38) TSHRPOLBAPEX1HTTTDP1
SCHEMBL1260101 0.90 TSHR (0.42) TSHRPOLBAPEX1HTTTDP1
SCHEMBL28251339 0.89 TSHR (0.48) TSHRPOLBAPEX1HTTTDP1
SCHEMBL1260811 0.89 TSHR (0.44) TSHRPOLBAPEX1HTTTDP1
SCHEMBL5673772 0.89 TSHR (0.44) TSHRPOLBAPEX1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240189121-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2024-06-13 US claimed
EP-3666299-B1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP (US) 2024-05-15 EP claimed
US-11903850-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2024-02-20 US claimed
US-20230036800-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2023-02-02 US claimed
US-11406514-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2022-08-09 US claimed
US-20220227954-A1 POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE OAKTREE FUND ADMINISTRATION, LLC 2022-07-21 US claimed
US-11369497-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2022-06-28 US claimed
EP-3862384-A2 POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE SiO2 Medical Products, Inc. (US) 2021-08-11 EP claimed
US-20210068991-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2021-03-11 US claimed
US-10835393-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2020-11-17 US claimed
EP-2875833-B1 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2018-08-08 EP claimed
US-20170232156-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2017-08-17 US claimed
US-9668890-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2017-06-06 US claimed
US-20150148882-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2015-05-28 US claimed
WO-2015077081-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP (US) 2015-05-28 WO claimed
EP-2875833-A1 Anti-thrombogenic medical devices and methods Covidien LP (US) 2015-05-27 EP claimed
US-20150140344-A1 COATED MEDICAL DEVICES COVIDIEN LP 2015-05-21 US claimed
US-20100094339-A1 COATING COMPOSITIONS COVIDIEN LP 2010-04-15 US claimed
EP-2120824-A1 COATING COMPOSITIONS Tyco Healthcare Group LP (US) 2009-11-25 EP claimed
WO-2008143654-A1 COATING COMPOSITIONS TYCO HEALTHCARE GROUP LP (US) 2008-11-27 WO claimed